Abstract
In 1907, Goldman described the characteristics of tumor vessels including their dilatation, accelerated proliferation and irregular arrangement. In 1939, Ide et al. were the first to suggest that tumors release specific factors capable of stimulating the growth of blood vessels. In 1945, Algire and Chalkley were the first to appreciate that growing malignancies could continuously elicit new capillary growth from the host. They used a transparent chamber implanted in a cat’s skin to study the vasoproliferative reaction secondary to a wound or implantation of normal or neoplastic tissues. They showed that the vasoproliferative response induced by tumor tissues was more substantial and earlier than that induced by normal tissues or following a wound. They found that capillaries arose from the host and that endothelial proliferation appeared as early as 3 days after implantation, weheras in wounds it did not begin for 6 days. Moreover, differentiation of vessels in vessels into arterioles and venules was not evident and the authors believe that an oustainding characteristic of the tumor cells was its capacity to elicit continued growth of new capillaries from the host: “This characteristic of the tumor cell, rather than some hypothetical capacity for autonomous growth inherent within the cell, is, from the standpoint of the host, an important expression of neoplastic change”. They concluded that the growth of a tumor is closely connected to the development of an intrinsic vascular network.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Algire GH, Chalkley HW (1945) Vascular reactions of mice to wound and to normal and neoplastic transplants. J Natl Cancer Inst 6:73–85
Aterton A (1977) Growth stimulation of endothelial cells by simultaneous culture with sarcoma 180 cells in diffusion chambers. Cancer Res 37:3619–3622
Ausprunk DH, Knighton DR, Folkman J (1974) Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 38:237–248
Ausprunk DH, Knighton DR, Folkman J (1975) Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am J Pathol 79:597–618
Bergers G, Song S, Mayer-Morse N et al (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287–1295
Brem S, Cotran R, Folkman J (1972) Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48:347–356
Brem S, Brem H, Folkman J et al (1976) Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res 36:2807–2812
Brem S, Gullino PM, Medina D (1977) Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science 195:880–882
Brem S, Jensen HM, Gullino PM (1978) Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41:239–244
Cairns RA, Khokha R, Hill RP (2003) Molecular mechanisms of tumor growth and metastasis: an integrated view. Curr Mol Med 3:659–671
Cao Y (2010) Angiogenesis: what can it offer for future medicine? Exp Cell Res 316:1304–1308
Casanovas O, Hicklin DJ, Bergers et al (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299–309
Castellani P, Boris L, Caremolla A et al (2002) Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. American J Pathol 161:1695–1700
Cavallo T, Sade R, Folkman J et al (1972) Tumor angiogenesis: rapid induction of endothelial mitosis demonstrated by autoradiography. J Cell Biol 54:408–420
Cavallo T, Sade R, Folkman J et al (1973) Ultrastructural autoradiographic studies of the early vasoproliferative response in tumor angiogenesis. Am J Pathol 70:345–362
Chodak GW, Haudenschild C, Gittes RF et al (1980) Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg 192:762–771
Denekamp J, Hobson B (1982) Endothelial cell proliferation in experimental tumors. Br J Cancer 46:711–720
Ebos JM, Lee CR, Christensen JG et al (2007) Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc Natl Acad Sci U S A 104:17069–17074
Ebos JM, Lee CR, Cruz-Munoz W et al (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15:232–239
Ehrman RL, Knoth M (1968) Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J Natl Cancer Inst 41:1329–1341
Erber R, Thurnher A, Katsen AD et al (2004) Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 18:338–340
Folkman J (1971) Tumor angiogenesis. Therapeutic implications. N Engl J Med 285:1182–1186
Folkman J (1990) Whas is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6
Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 94:883–893
Folkman J, Cotran R (1976) Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16:207–248
Folkman J, Hochberg M (1983) Self-regulation of growth in three dimensions. J Exp Med 138:745–753
Folkman MJ, Long DM, Becker FF (1963) Growth and metastasis of tumor in organ culture. Cancer 16:453–467
Folkman J, Watson K, Ingber D et al (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61
Gimbrone MA Jr, Gullino PM (1976a) Angiogenesis capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation. Cancer Res 36:2611–2620
Gimbrone MA Jr, Gullino PM (1976b) Neovascularization induced by intraocular xenografts of normal, preneoplastic and neoplastic mouse mammary tissue. J Natl Cancer Inst 56:305–318
Gimbrone MA Jr, Aster RH, Cotran RS et al (1969) Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 222:33–36
Gimbrone MA Jr, Cotran RS, Folkman J (1974a) Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60:673–684
Gimbrone MA Jr, Cotran RS, Folkman J (1974b) Tumor growth and neovascularization: an experimental model using rabbit cornea. J Natl Cancer Inst 52:413–427
Gimbrone MA, Leapman SB, Cotran RS et al (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261–276
Gimbrone MA, Leapman S, Cotran RS et al (1973) Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. J Natl Cancer Inst 50:219–228
Goldman E (1907) The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 2:1236–1237
Greenblatt M, Shubik P (1968) Tumor angiogenesis: transfilter diffusion studied in the hamster by the transparent chamber technique. J Natl Cancer Inst 41:1111–1124
Greene HSN (1941) Heterologous transplantation of mammalian tumors: I. The transfer of rabbit tumors to alien species. J Exp Med 73:461–474
Gullino PM, Grantham FH (1961) Studies on the exchange of fluids between host and tumor. The blood flow of hepatomas and other tumors in rats and mice. J Natl Cancer Inst 27:1465–1491
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Holmgren L, O’Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149–153
Hu-Lowe DD, Zou HY, Grazzini ML et al (2008) Non-clinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinase 1, 2, 3. Clin Cancer Res 14:7272–7283
Ide AG, Baker NH, Warren SL (1939) Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am J Roentg 32:891–899
Inai T, Mancuso M, Hashizume H et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165:35–52
Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987–989
Kandell J, Bossy-Wetzel E, Radvanyi F et al (1991) Neovascularization is associated with switch to the export of bFGF in the multispep development of fibrosarcoma. Cell 66:1095–1104
Knighton D, Ausprunk D, Tapper D et al (1977) Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 35:347–356
Kunkel P, Ulbricht U, Bohlen P et al (2001) Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 61:6624–6628
Lewis WH (1927) The vascular pattern of tumours. John Hopkins Hosp Bull 41:156–173
McCulloch P, Choy A, Martin L (1995) Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery. Lancet 346:1334–1335
Melwin RM, Algire GH (1956) The role of graft and host vessels in vascularization of grafts of normal and neoplastic tissues. J Natl Cancer Inst 17:23–33
Narayana A, Kelly P, Golfinos PJ et al (2008) Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. J Neurosurg 110:173–180
Nordern AD, Young GS, Setayesh K et al (2008) Bevacizumab for recurrent malignant gliomas: efficacy, toxicity and patterns of recurrence. Neurology 70:779–787
O’Reilly MS, Holmgren L, Shing Y et al (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79:315–328
Padera TP, Kuo AH, Hoshida T et al (2008) Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. Mol. Cancer Res 7:2272–2279
Paez-Ribes M, Allen A, Hudock J et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:222–231
Pennacchietti S, Michieli P, Galluzzo M et al (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347–361
Roskoski R Jr (2007) Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun. 356:323–328
Saidi A, Hagedorn M, Allain N et al (2009) Combined targeting of interleukin 6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer 125:1054–1064
Srivastava A, Ladler P, Davies R et al (1989) The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm) skin melanoma. Am J Pathol 133:419–423
St Croix B, Ragio C, Velculescu V et al (2000) Genes expressed in human tumor endothelium. Science 18:1197–1202
Urbach F (1961) The blood suplly of tumors. In: Montagna W, Ellis RA (eds) Advances of biology of the skin. Pergamon Press, New York, pp 123–149
Weidner N, Semple JP, Welch WR et al (1991) Tumor angiogenesis and metastasis– correlation in invasive breast carcinoma. N Engl J Med 324:1–8
Weidner N, Folkman J, Pozza F et al (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 84:1875–1887
Weidner N, Carroll PR, Flax J et al (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401–409
Weinstat-Saslow D, Steeg PS (1994) Angiogenesis and colonization in the tumor metastatc process: basic and applied advances. FASEB J 8:401–407
Wilhelm SM, Adnane L, Newell P et al (2008) Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 7:3129–3140
Xian X, Hakansson J, Stahlberg A et al (2006) Pericytes limit tumor cell metastasis. J Clin Invest 116:642–651
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ribatti, D. (2018). Tumor Angiogenesis. In: Judah Folkman. Springer, Cham. https://doi.org/10.1007/978-3-319-92633-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-92633-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92632-2
Online ISBN: 978-3-319-92633-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)